2026 SPS Denver | Tarlatamab and Tebentafusp Bispecifics: Clinical and Practical Considerations in the Solid Tumors Setting
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 23, 2026
- Last Review
- May 23, 2026
- Expires
- May 23, 2029
Target Audience
Pharmacists
Faculty & Disclosure
Faculty
Benjamin Yoder, PharmD, BCOP
Accreditation
NA
